Your browser doesn't support javascript.
loading
[Establishment of clinical features and prognostic scoring model in early-stage hepatitis B-related acute-on-chronic liver failure].
Wu, T Z; Liang, X; Li, J Q; Li, T; Yang, L L; Li, J; Xin, J J; Jiang, J; Shi, D Y; Ren, K K; Hao, S R; Jin, L F; Ye, P; Huang, J R; Xu, X W; Gao, Z L; Duan, Z P; Han, T; Wang, Y M; Wang, B J; Gan, J H; Fen, T T; Pan, C; Chen, Y P; Huang, Y; Xie, Q; Lin, S M; Chen, X; Xin, S J; Li, L J; Li, J.
Afiliación
  • Wu TZ; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Liang X; Precision Medicine Center, Taizhou Central Hospital, Taizhou University Medical School, Taizhou 318000, China.
  • Li JQ; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Li T; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Yang LL; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Li J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Xin JJ; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Precision Medicine Center, Taizhou Central Hospital, Taizho
  • Jiang J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Precision Medicine Center, Taizhou Central Hospital, Taizho
  • Shi DY; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Precision Medicine Center, Taizhou Central Hospital, Taizho
  • Ren KK; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Hao SR; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Jin LF; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Ye P; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Huang JR; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Xu XW; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Gao ZL; Department of Liver and Infectious Disease, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510000, China.
  • Duan ZP; Department of Liver and Infectious Diseases, Beijing YouAn Hospital, Capital Medical University, Beijing 100069, China.
  • Han T; Department of Liver and Infectious Diseases, Tianjin Third Central Hospital, Tianjin 300170, China.
  • Wang YM; Department of Liver and Infectious Disease, The First Hospital Affiliated To AMU, Chongqing 400038, China.
  • Wang BJ; Department of Liver and Infectious Disease, Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430022, China.
  • Gan JH; Department of Liver and Infectious Disease, The First Affilated Hospital of Soochow University, Suzhou 215006, China.
  • Fen TT; Department of Liver and Infectious Disease, The First Affilated Hospital of Soochow University, Suzhou 215006, China.
  • Pan C; Department of Liver and Infectious Diseases, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou 350005, China.
  • Chen YP; Department of Liver and Infectious Diseases, The First Affilated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
  • Huang Y; Department of Liver and Infectious Diseases, Xiangya Hospital Central South University, Changsha 410013, China.
  • Xie Q; Department of Liver and Infectious Diseases, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
  • Lin SM; Department of Liver and Infectious Diseases, First Affilated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
  • Chen X; Institute of Pharmaceutical Biotechnology, Zhejiang University School of Medicine, Hangzhou 310058, China; Precision Medicine Center, Taizhou Central Hospital, Taizhou University Medical School, Taizhou 318000, China.
  • Xin SJ; Department of liver and Infectious Diseases, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
  • Li LJ; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
  • Li J; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Precision Medicine Center, Taizhou Central Hospital, Taizho
Zhonghua Gan Zang Bing Za Zhi ; 28(4): 310-318, 2020 Apr 20.
Article en Zh | MEDLINE | ID: mdl-32403883
ABSTRACT

Objective:

To explore the clinical characteristics and establish a corresponding prognostic scoring model in patients with early-stage clinical features of hepatitis B-induced acute-on-chronic liver failure (HBV-ACLF).

Methods:

Clinical characteristics of 725 cases with hepatitis B-related acute-on-chronic hepatic dysfunction (HBV-ACHD) were retrospectively analyzed using Chinese group on the study of severe hepatitis B (COSSH). The independent risk factors associated with 90-day prognosis to establish a prognostic scoring model was analyzed by multivariate Cox regression, and was validated by 500 internal and 390 external HBV-ACHD patients.

Results:

Among 725 cases with HBV-ACHD, 76.8% were male, 96.8% had cirrhosis base,66.5% had complications of ascites, 4.1% had coagulation failure in respect to organ failure, and 9.2% had 90-day mortality rate. Multivariate Cox regression analysis showed that TBil, WBC and ALP were the best predictors of 90-day mortality rate in HBV-ACHD patients. The established scoring model was COSS-HACHADs = 0.75 × ln(WBC) + 0.57 × ln(TBil)-0.94 × ln(ALP) +10. The area under the receiver operating characteristic curve (AUROC) of subjects was significantly higher than MELD, MELD-Na, CTP and CLIF-C ADs(P < 0.05). An analysis of 500 and 390 cases of internal random selection group and external group had similar verified results.

Conclusion:

HBV-ACHD patients are a group of people with decompensated cirrhosis combined with small number of organ failure, and the 90-day mortality rate is 9.2%. COSSH-ACHDs have a higher predictive effect on HBV-ACHD patients' 90-day prognosis, and thus provide evidence-based medicine for early clinical diagnosis and treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Insuficiencia Hepática Crónica Agudizada Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hepatitis B Crónica / Insuficiencia Hepática Crónica Agudizada Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: Zh Revista: Zhonghua Gan Zang Bing Za Zhi Asunto de la revista: GASTROENTEROLOGIA Año: 2020 Tipo del documento: Article País de afiliación: China